Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 16 tweets from 12 users, with an upper bound of 35,521 followers.

Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer. https://t.co/LVJnWA4Y2o

#JITC Research: Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer https://t.co/vUAFU0rh6e https://t.co/zSS4IsNK3E

RT @sitcancer: #JITC Research: Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of…

#JITC Research: Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer https://t.co/vUAFU0rh6e https://t.co/GQTz21NW1l

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 12 additional tweets.